Veru Reports Record Fiscal 2021 Full-Year Financial Results

NEXT STORY
Surface Oncology to Present New Clinical Data from Ongoing SRF617 Phase 1 Trial at the European Society for Medical Oncology Immuno-Oncology Congress (ESMO-IO) 2021
PREV STORY
X4 Pharmaceuticals to Host Virtual Seminar “Understanding Primary Immunodeficiencies” to Highlight Broadening Market Opportunities for Mavorixafor
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

UroGen Pharma to Ring the Nasdaq Stock Market Opening Bell

RA’ANANA, Israel and NEW YORK, June 02, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. ...

author_avatar
NASDAQ Market News

MediWound Announces Positive Outcome of Interim Assessment for its EscharEx U.S. Phase 2 Adaptive Design Study

author_avatar
NASDAQ Market News

Blueberries Medical Reports 2021 Q2 Financial Results and Provides Corporate and Operations Update

author_avatar
NASDAQ Market News